Moleculin Biotech (MBRX) Invested Capital (2019 - 2022)
Moleculin Biotech (MBRX) posted quarterly Invested Capital of $86000.0 for Q4 2022, down 21.1% year-over-year from $109000.0 in Q4 2021, and down 21.82% quarter-over-quarter from $110000.0 in Q3 2022.
Moleculin Biotech (MBRX) Invested Capital (2019 - 2022) Analysis & Trends
Moleculin Biotech's Invested Capital history runs 4 years deep, the most recent figure standing at $86000.0 for Q4 2022.
- In Q4 2022, Invested Capital fell 21.1% year-over-year to $86000.0; the TTM figure through Sep 2023 stood at $86000.0 (down 80.37% YoY), while the FY2022 annual figure was $86000.0, down 21.1% from the prior year.
- Invested Capital for Q4 2022 stood at $86000.0, down from $110000.0 in the prior quarter.
- The five-year high for Invested Capital was $124000.0 in Q1 2022, with the low at $78000.0 in Q4 2020.
- The 4-year median for Invested Capital is $99000.0 (2019), against an average of $99444.4.
- The sharpest annual moves came in 2020 and 2021: Invested Capital fell 21.21% in 2020, then surged 39.74% in 2021.
- Moleculin Biotech's Invested Capital stood at $99000.0 in 2019, then slipped by 21.21% to $78000.0 in 2020, then soared by 39.74% to $109000.0 in 2021, then slipped by 21.1% to $86000.0 in 2022.
- Business Quant data shows MBRX's Invested Capital at $86000.0 in Q4 2022, $110000.0 in Q3 2022, and $95000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 190.90 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.45 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 380.00 Mn |
| 10 | Moleculin Biotech | 3.37 Mn | 3.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 86,000.00 |
| Sep 30, 2022 | 110,000.00 |
| Jun 30, 2022 | 95,000.00 |
| Mar 31, 2022 | 124,000.00 |
| Dec 31, 2021 | 109,000.00 |
| Mar 31, 2021 | 95,000.00 |
| Dec 31, 2020 | 78,000.00 |
| Sep 30, 2020 | 99,000.00 |
| Dec 31, 2019 | 99,000.00 |